Literature DB >> 7684473

Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen.

G Borisova1, B Arya, A Dislers, O Borschukova, V Tsibinogin, D Skrastina, M A Eldarov, P Pumpens, K G Skryabin, E Grens.   

Abstract

A hepatitis B core antigen (HBcAg) gene bearing the 39-amino-acid-long domain A of hepatitis B surface antigen (HBsAg) within the HBcAg immunodominant loop has been constructed and expressed in Escherichia coli. Chimeric capsids demonstrated HBs but not HBc antigenicity and elicited in mice B-cell and T-cell responses against native HBcAg and HBsAg.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7684473      PMCID： PMC237728     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  25 in total

1.  Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides.

Authors:  S E Brown; C R Howard; A J Zuckerman; M W Steward
Journal:  Lancet       Date:  1984-07-28       Impact factor: 79.321

2.  Antigenic structure of hepatitis B surface antigen: identification of the "d" subtype determinant by chemical modification and use of monoclonal antibodies.

Authors:  D L Peterson; D A Paul; J Lam; I I Tribby; D T Achord
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

3.  Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein, the hepatitis B surface antigen.

Authors:  A R Neurath; S B Kent; N Strick
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

4.  Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides.

Authors:  G R Dreesman; Y Sanchez; I Ionescu-Matiu; J T Sparrow; H R Six; D L Peterson; F B Hollinger; J L Melnick
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

5.  A synthetic peptide with hepatitis B surface antigen reactivity.

Authors:  T P Hopp
Journal:  Mol Immunol       Date:  1981-09       Impact factor: 4.407

6.  A glycopeptide containing 15 amino acid residues derived from hepatitis B surface antigen particles: demonstration of immunogenicity to raise anti-HBs in mice.

Authors:  A Machida; S Kishimoto; H Ohnuma; H Miyamoto; K Baba; K Oda; T Nakamura; G Funatsu; Y Miyakawa; M Mayumi
Journal:  Mol Immunol       Date:  1982-09       Impact factor: 4.407

7.  The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.

Authors:  F Schödel; A M Moriarty; D L Peterson; J A Zheng; J L Hughes; H Will; D J Leturcq; J S McGee; D R Milich
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

8.  Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.

Authors:  P K Bhatnagar; E Papas; H E Blum; D R Milich; D Nitecki; M J Karels; G N Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

9.  Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees.

Authors:  J L Gerin; H Alexander; J W Shih; R H Purcell; G Dapolito; R Engle; N Green; J G Sutcliffe; T M Shinnick; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

10.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962
View more
  10 in total

1.  Construction of prokaryotic expression system of TGF-beta1 epitope gene and identification of recombinant fusion protein immunity.

Authors:  Yong-Hong Guo; Zhi-Ming Hao; Jin-Yan Luo; Jun-Hong Wang
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

2.  T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles.

Authors:  T Fehr; D Skrastina; P Pumpens; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

3.  DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease.

Authors:  Purevdorj B Olkhanud; Mohammed Mughal; Koichi Ayukawa; Enkhzol Malchinkhuu; Monica Bodogai; Neil Feldman; Sarah Rothman; Jong-Hwan Lee; Srinivasulu Chigurupati; Eitan Okun; Kunio Nagashima; Mark P Mattson; Arya Biragyn
Journal:  Vaccine       Date:  2012-01-14       Impact factor: 3.641

4.  Cryo-EM study of Hepatitis B virus core antigen capsids decorated with antibodies from a human patient.

Authors:  Eaazhisai Kandiah; Norman R Watts; Naiqian Cheng; Giovanni Cardone; Stephen J Stahl; Theo Heller; T Jake Liang; Paul T Wingfield; Alasdair C Steven
Journal:  J Struct Biol       Date:  2011-10-25       Impact factor: 2.867

5.  Insertions within the hepatitis B virus capsid protein influence capsid formation and RNA encapsidation.

Authors:  B Beames; R E Lanford
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Baculovirus expression of chimeric hepatitis B virus core particles with hepatitis E virus epitopes and their use in a hepatitis E immunoassay.

Authors:  A Touze; N Enogat; Y Buisson; P Coursaget
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

7.  Phenotypic mixing between different hepadnavirus nucleocapsid proteins reveals C protein dimerization to be cis preferential.

Authors:  C Chang; S Zhou; D Ganem; D N Standring
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

Review 8.  Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C.

Authors:  Makutiro Ghislain Masavuli; Danushka K Wijesundara; Joseph Torresi; Eric J Gowans; Branka Grubor-Bauk
Journal:  Front Microbiol       Date:  2017-12-05       Impact factor: 5.640

9.  Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.

Authors:  Izzat Fahimuddin Bin Mohamed Suffian; Julie Tzu-Wen Wang; Naomi O Hodgins; Rebecca Klippstein; Mitla Garcia-Maya; Paul Brown; Yuya Nishimura; Hamed Heidari; Sara Bals; Jane K Sosabowski; Chiaki Ogino; Akihiko Kondo; Khuloud T Al-Jamal
Journal:  Biomaterials       Date:  2016-12-14       Impact factor: 12.479

10.  Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes.

Authors:  F Schödel; R Wirtz; D Peterson; J Hughes; R Warren; J Sadoff; D Milich
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.